Skip to main content
. 2021 Mar 8;27(13):2031–2039. doi: 10.1177/1352458521999274

Table 1.

Subject demographics, cognition and MRI measures.

Healthy controls (N = 82) Early RRMS (N = 149) Late RRMS (N = 81) SPMS (N = 48)
Mean SD Mean SD Mean SD Mean SD
Demographics
Age (years) 45.93 10.79 41.39 9.29 b 51.97 8.54 b 55.05 8.38b,*
Sex (% women) 63 73 79 69
Education a 6.00 1.0–7.0 5.00 1.0–7.0 5.00 1.0–7.0 4.00 1.0–7.0
Disease duration (years) 7.93 2.60 21.78 4.65 21.26 9.46 *
EDSS a 2.50 0–6 3.00 1–7.5 6.00 2.5–8.0b,*
Cognition (Z-scores)
Executive functioning −0.05 0.73 −0.67 1.19 b −1.05 2.16 b −1.42 1.69b,*
Verbal memory 0.00 0.87 −0.34 1.02 −0.41 1.20 −0.85 1.28 b
IPS −0.06 0.92 −0.79 1.25 b −1.23 1.34 b −1.73 1.37b,*
Verbal fluency −0.04 1.00 −0.31 1.07 −0.57 0.96 −0.71 1.10
Visuospatial memory 0.00 0.91 −0.35 1.15 −0.74 1.18 b −0.95 1.06 b
Working memory 0.00 0.85 −0.68 1.09 b −1.06 1.76 b −1.73 1.35b,*
Attention −0.07 0.66 −0.51 0.87 b −0.78 1.25 b −0.67 1.11 b
Average cognition −0.03 0.48 −0.53 0.73 b −0.85 1.09 b −1.19 0.94b,*
Structural damage
WB-LV (mL) a 7.05 0.59–40.77 14.75 0.93–60.08 18.79 2.06–84.85 *
C-LV (mL) a 0 0–0.34 0 0–0.23 0 0–0.11
NBV (L) 1.51 0.07 1.48 0.06 b 1.43 0.08 b 1.41 0.08b,*
Cerebellar NGMV (L) 0.11 0.01 0.11 0.01 0.10 0.01 b 0.09 0.01b,*
Cerebellar FA 0.19 0.02 0.18 0.02 b 0.17 0.02 b 0.17 0.02b,*

MRI: magnetic resonance imaging; SD: standard deviation; GLM: general linear model (main effect); education: highest level of education attained (on a scale of 1–7); EDSS: Expanded Disability Status Scale; IPS: information processing speed; WB-LV: T2-lesion volume of the whole brain; C-LV: T2-lesion volume in the cerebellum; NBV: normalized brain volume; NGMV: normalized grey matter volume; FA: grey matter fractional anisotropy; cerebellar connectivity: averaged static connectivity of the cerebellum with the rest of the brain.

a

The values are represented in median and range.

b

Indicates values significantly different from healthy control values.

*

Indicates a significant difference between secondary progressive and early relapsing-remitting multiple sclerosis (both at p < 0.05, corrected).